Unproven "Stem Cell" Interventions in the U.S.: Ethical, Scientific, & Regulatory Concerns

MBA Header
This is the second session of the Center for Bioethics' Mini Bioethics Academy, designed for people to learn about and foster discussion on bioethical challenges in today's society. Mini Bioethics Academy is open to anyone interested in learning more about bioethics.

Session Description: Health researchers have studied “stem cell tourism” to clinics in countries such as China, India, Mexico, Thailand, and the Ukraine but more recently, studies have found hundreds of clinics here in the U.S. selling unapproved and unproven stem cell interventions. Many of these clinics do not sell FDA-approved stem cell products or have credible  evidence supporting their marketing claims.  This direct-to-consumer approach to selling unproven and unlicensed cell-based products prompts troubling concerns about patient safety, the manipulation of hope in advertising, and the gap between the current state of stem cell research and the purported therapies these clinics market.

In this talk, Leigh Turner, PhD, will describe the U.S. direct-to-consumer marketplace for stem cell interventions and explore ethical issues related to the increase in U.S. clinics selling stem cell treatments. The presentation will also cover regulation of stem cell-based products, FDA enforcement activity, and lawsuits filed by former patients of U.S. stem cell clinics. 

Register here: https://www.tickets.umn.edu/UMATO/Online/article/BioethicsMBA2019

Individual Sessions:
Adults/General Public: $10 Advance / $15 at Door
Students: $5
Online registration ends at 4:30 pm the night before. Walk-in registration begins 6 pm the day of the event.

Seating is limited; advanced registration is encouraged.

Event date: 
Wednesday, May 1, 2019 - 6:30pm to 8:00pm
Event location: 
2-690 Moos Tower
515 Delaware St SE
Minneapolis, MN 55455